<html>
<head>PUBMED IDs for PITPNM3</head>
<body bgcolor='#C5F0F2'><h1>PITPNM3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18188949/'>Mutation in the PYK2-binding domain of PITPNM3 causes autosomal dominant cone dystrophy (CORD5) in two Swedish families.</a> January 15  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20590364/'>PITPNM3 is an uncommon cause of cone and cone-rod dystrophies.</a> October 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22405330/'>Ocular phenotype of CORD5, an autosomal dominant retinal dystrophy associated with PITPNM3 p.Q626H mutation.</a> September 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/26416449/'>CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.</a> August 31  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26449829/'>CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-ÎºB signaling pathway in hepatocellular carcinoma.</a> February 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28290464/'>Blocking the recruitment of naive CD4(+) T cells reverses immunosuppression in breast cancer.</a> March 15  2017<br></body></html>
